{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:06:53Z","timestamp":1794672413276,"version":"4.9.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,1,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Erectile dysfunction (ED) is a highly prevalent disorder associated with a significant burden of illness. The prevalence and incidence of ED are strongly age-related, affecting more than half of men &amp;gt;60 years. The first Princeton Consensus Conference (Princeton I) in 1999 developed guidelines for safe management of cardiac patients regarding sexual activity and the treatment of ED.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>The second conference (Princeton II) was convened to update the recommendations based on the expanding knowledge base and new treatments available. This article reviews and expands on the Princeton II guidelines to address sexual dysfunction and cardiac risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A consensus panel of experts reviewed recent multinational studies in safety and drug interaction data for three phosphodiesterase type 5 (PDE5) inhibitors (sildenafil, tadalafil, vardenafil), with emphasis on the safety of these agents in men with ED and concomitant cardiovascular disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Erectile dysfunction is an early symptom or harbinger of cardiovascular disease, due to the common risk factors and pathophysiology mediated through endothelial dysfunction. Major comorbidities include diabetes, hypertension, hyperlipidemia and heart disease. Any asymptomatic man who presents with ED that does not have an obvious cause (e.g., trauma) should be screened for vascular disease and have blood glucose, lipids, and blood pressure measurements. Ideally, all patients at risk but asymptomatic for coronary disease should undergo an elective exercise electrocardiogram to facilitate risk stratification. Lifestyle intervention in ED, specifically weight loss and increased physical activity, particularly in patients with ED and concomitant cardiovascular disease, is literature-supported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The recognition of ED as a warning sign of silent vascular disease has led to the concept that a man with ED and no cardiac symptoms is a cardiac (or vascular) patient until proven otherwise. Men with ED and other cardiovascular risk factors (e.g., obesity, sedentary lifestyle) should be counseled in lifestyle modification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1743-6109.2005.00196.x","type":"journal-article","created":{"date-parts":[[2006,1,5]],"date-time":"2006-01-05T03:38:25Z","timestamp":1136432305000},"page":"28-36","source":"Crossref","is-referenced-by-count":263,"title":["The Second Princeton Consensus on Sexual Dysfunction and Cardiac Risk: New Guidelines for Sexual Medicine"],"prefix":"10.1093","volume":"3","author":[{"given":"Graham","family":"Jackson","sequence":"first","affiliation":[{"name":"Cardiothoracic Center St Thomas\u2019 Hospital , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond C.","family":"Rosen","sequence":"additional","affiliation":[{"name":"University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School , New Brunswick , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Kloner","sequence":"additional","affiliation":[{"name":"Keck School of Medicine University of Southern California , Los Angeles , USA"},{"name":"Heart Institute of Good Samaritan Hospital , Los Angeles , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Kostis","sequence":"additional","affiliation":[{"name":"University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School , New Brunswick , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,1,1]]},"reference":[{"key":"2024032600194513900_bib1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1046\/j.1464-410x.1999.00142.x","article-title":"The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences","volume":"84","author":"Ayta","year":"1999","journal-title":"BJU Int"},{"key":"2024032600194513900_bib2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1006\/pmed.2000.0643","article-title":"Erectile dysfunction and coronary risk factors: Prospective results from the Massachusetts Male Aging Study","volume":"30","author":"Feldman","year":"2000","journal-title":"Prev Med"},{"key":"2024032600194513900_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/heart.89.3.251","article-title":"Erectile dysfunction and the cardiovascular patient: Endothelial dysfunction is the common denominator","volume":"89","author":"Solomon","year":"2003","journal-title":"Heart"},{"key":"2024032600194513900_bib4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0002-9149(00)00896-1","article-title":"Management of sexual dysfunction in patients with cardiovascular disease; the Princeton Consensus Panel","volume":"86","author":"DeBusk","year":"2000","journal-title":"Am J Cardiol"},{"key":"2024032600194513900_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.amjcard.2005.03.065","article-title":"Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference)","volume":"96","author":"Kostis","year":"2005","journal-title":"Am J Cardiol"},{"key":"2024032600194513900_bib6","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1742-1241.2001.tb11141.x","article-title":"Is erectile dysfunction a marker for cardiovascular disease?","volume":"55","author":"Kirby","year":"2001","journal-title":"Int J Clin Pract"},{"key":"2024032600194513900_bib7","first-page":"3751","article-title":"The penile stress test: A window to the heart of the man [abstract]?","volume":"100","author":"Pritzker","year":"1999","journal-title":"Circulation"},{"key":"2024032600194513900_bib8","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0002-9149(02)03113-2","article-title":"Relation of erectile dysfunction to angiographic coronary artery disease","volume":"91","author":"Solomon","year":"2003","journal-title":"Am J Cardiol"},{"key":"2024032600194513900_bib9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.ijir.3900282","article-title":"Does severity of ischaemic coronary disease correlate with erectile function?","volume":"9","author":"Greenstein","year":"1997","journal-title":"Int J Impot Res"},{"key":"2024032600194513900_bib10","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0302-2838(03)00307-5","article-title":"Is erectile dysfunction the \u201cTip of the Iceberg\u201d of a systemic vascular disorder?","volume":"44","author":"Montorsi","year":"2003","journal-title":"Eur Urol"},{"key":"2024032600194513900_bib11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1742-1241.2005.00453.x","article-title":"Endothelial dysfunction links erectile dysfunction to heart disease?","volume":"59","author":"Kirby","year":"2005","journal-title":"Int J Clin Pract"},{"key":"2024032600194513900_bib12","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0302-2838(03)00305-1","article-title":"Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease","volume":"44","author":"Montorsi","year":"2003","journal-title":"Eur Urol"},{"key":"2024032600194513900_bib13","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1742-1241.2003.tb10434.x","article-title":"Erectile dysfunction: Cardiovascular risk and the role of the cardiologist","volume":"57","author":"Solomon","year":"2003","journal-title":"Int J Clin Pract"},{"key":"2024032600194513900_bib14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0167-5273(02)00421-7","article-title":"Coronary and systemic haemodynamic effects of sildenafil citrate: From basic science to clinical studies in patients with cardiovascular disease","volume":"86","author":"Gillies","year":"2002","journal-title":"Int J Cardiol"},{"key":"2024032600194513900_bib15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.amjcard.2005.03.097","article-title":"Evaluation of acute risk for myocardial infarction in men treated with sildenafil citrate","volume":"96","author":"Mittleman","year":"2005","journal-title":"Am J Cardiol"},{"key":"2024032600194513900_bib16","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1368-5031.2005.00578.x","article-title":"Past, present and future: A 7-year update of Viagra (sildenafil citrate)","volume":"59","author":"Jackson","year":"2005","journal-title":"Int J Clin Pract"},{"key":"2024032600194513900_bib17","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.ehj.2003.09.021","article-title":"Sildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable angina","volume":"24","author":"Fox","year":"2003","journal-title":"Eur Heart J"},{"key":"2024032600194513900_bib18","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1056\/NEJM200006013422201","article-title":"Haemodynamic effects of sildenafil in men with severe coronary artery disease","volume":"342","author":"Herrman","year":"2000","journal-title":"N Engl J Med"},{"key":"2024032600194513900_bib19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1743-6109.2004.04024.x","article-title":"Update on clinical trials of tadalafil demonstrates no increased risk of cardiovascular adverse events","volume":"1","author":"Jackson","year":"2004","journal-title":"J Sex Med"},{"key":"2024032600194513900_bib20","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/S0735-1097(02)02563-9","article-title":"The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease","volume":"40","author":"Thadani","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2024032600194513900_bib21","author":"Levitra\u00ae","year":"2005"},{"key":"2024032600194513900_bib22","author":"Sildenafil","year":"2004"},{"key":"2024032600194513900_bib23","author":"Cialis","year":"2005"},{"key":"2024032600194513900_bib24","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1001\/jama.290.23.3129","article-title":"Sexual activity in patients with angina","volume":"290","author":"DeBusk","year":"2003","journal-title":"JAMA"},{"key":"2024032600194513900_bib25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0735-1097(98)00656-1","article-title":"ACC\/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology\/American Heart Association","volume":"33","author":"Cheitlin","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"2024032600194513900_bib26","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.jacc.2003.09.023","article-title":"Time course of the interaction between tadalafil and nitrates","volume":"42","author":"Kloner","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2024032600194513900_bib27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0895-7061(00)01177-8","article-title":"Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy","volume":"14","author":"Kloner","year":"2001","journal-title":"Am J Hypertens"},{"key":"2024032600194513900_bib28","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1097\/00004872-200018120-00022","article-title":"Effect of sildenafil citrate on blood pressure and heart rate in men with erectile dysfunction taking concomitant antihypertensive medication. Sildenafil Study Group","volume":"18","author":"Zusman","year":"2000","journal-title":"J Hypertens"},{"issue":"4 suppl 1","key":"2024032600194513900_bib29","doi-asserted-by":"crossref","first-page":"A55","DOI":"10.1016\/S0895-7061(02)02415-9","article-title":"Safety of Viagra (sildenafil citrate) in men with erectile dysfunction and arterial hypertension who are taking multiple antihypertensive treatments","volume":"15","author":"Pickering","year":"2002","journal-title":"Am J Hypertens"},{"key":"2024032600194513900_bib30","article-title":"Efficacy and safety of vardenafil, a selective phosphodiesterase 5 inhibitor, in men with erectile dysfunction on antihypertensive therapy","volume-title":"Presented at the American Society of Hypertension 17th Annual Scientific Meeting","author":"Padma-Nathan","year":"2002"},{"issue":"suppl","key":"2024032600194513900_bib31","doi-asserted-by":"crossref","first-page":"47M","DOI":"10.1016\/S0002-9149(03)00075-4","article-title":"Cardiovascular effects of tadalafil in patients on common antihypertensive therapies","volume":"92","author":"Kloner","year":"2003","journal-title":"Am J Cardiol"},{"key":"2024032600194513900_bib32","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1097\/01.ju.0000142687.75577.e4","article-title":"Interaction between the phosphodiesterase 5 inhibitor, tadalafil, and the two alpha blockers: Doxazosin, tamsulosin in healthy normotensive men","volume":"172","author":"Kloner","year":"2004","journal-title":"J Urol"},{"key":"2024032600194513900_bib33","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.ijir.3901010","article-title":"Prevalence of erectile dysfunction and associated factors among men without concomitant diseases: A population study","volume":"15","author":"Nicolosi","year":"2003","journal-title":"Int J Impot Res"},{"key":"2024032600194513900_bib34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/sj.ijir.3901333","article-title":"Obesity, the metabolic syndrome and sexual dysfunction","volume":"17","author":"Esposito","year":"2005","journal-title":"Int J Impot Res"},{"key":"2024032600194513900_bib35","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1185\/030079904125003467","article-title":"The multinational men's attitudes of life events and sexuality (MALES) study: Prevalence of erectile dysfunction and related health concerns in the general population","volume":"20","author":"Rosen","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"2024032600194513900_bib36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-139-3-200308050-00005","article-title":"Sexual function in men older than 50 years of age: Results from the Health Professionals Follow-Up Study","volume":"139","author":"Bacon","year":"2003","journal-title":"Ann Intern Med"},{"key":"2024032600194513900_bib37","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0090-4295(00)01091-8","article-title":"Erectile and ejaculatory dysfunction in a community-based sample of men 50\u201378 years old: Prevalence, concerns and relation to sexual activity","volume":"57","author":"Blanker","year":"2001","journal-title":"Urology"},{"key":"2024032600194513900_bib38","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1046\/j.1532-5415.2001.49088.x","article-title":"Correlates for erectile and ejaculatory dysfunction in older Dutch men: A community-based study","volume":"49","author":"Blanker","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"2024032600194513900_bib39","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(05)66911-5","article-title":"Men in Australia, Telephone Survey (MATeS) I: A national survey of the reproductive health and concerns of middle aged and older Australian men","volume":"366","author":"Holden","year":"2005","journal-title":"Lancet"},{"key":"2024032600194513900_bib40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sj.ijir.3901250","article-title":"Sexual problems among women and men aged 40\u201380 years: Prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviour","volume":"17","author":"Laurmann","year":"2005","journal-title":"Int J Impot Res"},{"key":"2024032600194513900_bib41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.ijir.3901010","article-title":"Prevalence of erectile dysfunction and associated factors among men without concomitant diseases: A population study","volume":"15","author":"Nicolosi","year":"2003","journal-title":"Int J Impot Res"},{"key":"2024032600194513900_bib42","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1001\/jama.291.24.2978","article-title":"Effect of lifestyle changes on erectile dysfunction in obese men: A randomized controlled trial","volume":"291","author":"Esposito","year":"2004","journal-title":"JAMA"},{"key":"2024032600194513900_bib43","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/01.ju.0000132389.97804.d7","article-title":"Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone","volume":"172","author":"Shabsigh","year":"2004","journal-title":"J Urol"},{"key":"2024032600194513900_bib44","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1210\/jc.2003-030611","article-title":"Endogenous sex hormones and cardiovascular disease in men","volume":"88","author":"Muller","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032600194513900_bib45","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0735-1097(00)00790-7","article-title":"Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow mediated vasodilatation in patients with chronic heart failure","volume":"36","author":"Katz","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2024032600194513900_bib46","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2337\/diacare.25.8.1336","article-title":"Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes","volume":"25","author":"DeSouza","year":"2002","journal-title":"Diabetes Care"},{"key":"2024032600194513900_bib47","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0735-1097(02)02139-3","article-title":"The effect of sildenafil on human vascular function platelet activation and myocardial ischaemia","volume":"40","author":"Halcox","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2024032600194513900_bib48","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1742-1241.2002.tb11281.x","article-title":"Sildenafil for primary pulmonary hypertension: Short and long-term symptomatic benefit","volume":"56","author":"Jackson","year":"2002","journal-title":"Int J Clin Pact"},{"key":"2024032600194513900_bib49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1527-5299.2002.00288.x","article-title":"Potential role of type 5 phosphodiesterase inhibition in the treatment of congestive heart failure","volume":"9","author":"Katz","year":"2003","journal-title":"Congest Heart Fail"},{"key":"2024032600194513900_bib50","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.jhh.1001244","article-title":"Effect of sildenafil on blood pressure and arterial wave reflection in treated hypertensive men","volume":"15","author":"Mahmud","year":"2001","journal-title":"J Hum Hypertens"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515312868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515312868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/3\/1\/28\/47743248\/jsm_3_1_28.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/3\/1\/28\/47743248\/jsm_3_1_28.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T21:13:34Z","timestamp":1711401214000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/3\/1\/28\/6883729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,1]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2006,1,1]]},"published-print":{"date-parts":[[2006,1,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2005.00196.x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.12622.470104","asserted-by":"object"}]},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,1]]},"published":{"date-parts":[[2006,1,1]]}}}